histology mesothelioma
The prognosis in patients with malignant pleural mesothelioma is difficult to assess consistently because there is some variation in the time before diagnosis and the rate progression of malignant pleural mesothelioma. A series of surgical routines can be applied in selected patients, offering long-term survival without cure. In most of pleural mesothelioma patients, important prognostic factors include age, stage, histology and performance status.
For individuals treated with aggressive surgical routines, the factors associated with improved long-term survival are negative surgical margins, lymph node negative and epithelial histology. A record of exposure to asbestos is reported in 75% of all cases of mesothelioma.
Cellular Classification
Histologically, mesothelioma tumors are composed of epithelial and fibrous. According to a recent study, the epithelial form causes a lot of confusion with metastatic carcinomas. A needle biopsy of the pleura is not going to be effective in diagnosis. It is difficult to distinguish between mesothelioma and cancer in small tissue samples. However, thoracoscopy can be very useful to find the correct tissue samples for diagnostic purposes. Examination of macroscopic tumor at the time of surgery may also be useful and the use of electron microscopy is recommended.
Stage Information
People with stage I disease have a much better prognosis compared with those with stage II or III. Because malignant with Pleural Mesothelioma is fairly rare, there is little information available on survival. The classification system is established on the basis of Thoracic Surgery and the TNM classification system.
- Stage I: Malignant pleural mesothelioma confined within the capsule of the parietal pleura
- Stage II: All that is in Phase I with positive intrathoracic lymph nodes
- Stage III: Extended Local malignant pleural mesothelioma in the chest wall and heart
- Stage IV: distant metastases disease
Treatment options
We recommend that you go to a standard treatment instead of aggressive. There are a number of side effects associated with routine treatment aggressive. An extra-pleural pneumonectomy in some patients may be effective in the long term. Recent research decortication and pleurectomy may relieving symptoms and pain spills occur due to tumor burden. The use of radiotherapy and chemotherapy after surgery also gives temporary relief.
Localized malignant mesothelioma
- Solitary mesothelioma: Surgical resection en bloc consisting of the contiguous structures, which play a prominent role in getting rid of symptoms. The doctor will use sessile polyps
- Intracavitary mesothelioma: mesothelioma is treated with intracavitary through radiation therapy. In some cases, you will also find extrapleural pneumonectomy.
Advanced treatment options Malignant Mesothelioma
- Symptomatic treatment, including thoracoscopic pleurodesis, drainage of effusions and chest tube pleurodesis
- Palliative surgical resection is also being made in some individuals
- Palliative radiation therapy
- Single agent chemotherapy
- Intracavitary therapy is performed in selected patients. It includes the intrapleural and intraperitoneal administration of chemotherapeutic agents. Some of the agents chemotherapeutic agents used in therapy are cytarabine, cisplatin and mitomycin. These agents play an important role in minimizing the size of the tumor and pain control.
Recurrent malignant mesothelioma
Recurrent malignant mesothelioma treatment typically uses the routines and agents not used initially. There is no standard treatment currently available that can control symptoms in patients with malignant pleural mesothelioma.
Resources: Learning About Malignant Pleural Mesothelioma
About the Author:
Article Source: ArticlesBase.com – Learning About Malignant Pleural Mesothelioma
